New pressures in solubility, targeting precision and injectable usability are forcing drug delivery to evolve across formulation, mechanism and delivery method. This In-Depth Focus explores the approaches beginning to reshape performance outcomes across the development pipeline.
Drug delivery is being reshaped across formulation science, mechanistic targeting and device design, as the industry looks to improve performance, scalability and clinical translation in increasingly complex therapies. This In-Depth Focus brings together perspectives from JRS Pharma, Vetter Pharma and leading academic researchers on the technologies driving that shift.
Drug delivery is now defined by the challenge of moving complex therapeutics from formulation design into predictable real-world performance. Poor solubility, biological barriers to targeting and increasing expectations around usability are forcing change across the entire development pathway. As a result, innovation is no longer confined to individual disciplines, but is emerging across formulation science, mechanistic targeting strategies and device engineering.
This collection includes work from Tony Carpanzano (Director of R&D, JRS Pharma LP), Daniela Geiger (Product and Service Manager, Vetter Pharma) and leading academic researchers in mechanistically targeted drug delivery, highlighting how lipid-based formulation strategies, shear-activated nanoparticle systems and next-generation syringe technologies are addressing these challenges in practice.
See how new approaches in drug delivery are addressing key challenges in performance, scalability and clinical translation across targeting, formulation and device systems.
What’s inside this In-Depth Focus
- How lipid-based formulation strategies are being used to improve dissolution and bioavailability in poorly soluble drug compounds
- Why solid-dose conversion techniques are emerging as a more scalable alternative to traditional lipid-based manufacturing approaches
- How shear-activated nanoparticle systems are enabling mechanically targeted drug delivery in ischaemic stroke
- What recent advances suggest about expanding delivery beyond occluded vessels to support collateral circulation and tissue survival
- How next-generation syringe closure systems are addressing usability, safety and reliability challenges in injectable drug administration
Read the full In-Depth Focus to understand not just how drug delivery is evolving, but what it means for formulation design, delivery performance and clinical translation in your development pipeline.
Download Now
No comments yet